{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:33:07Z","timestamp":1791923587789,"version":"4.3.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,9]]},"DOI":"10.7759\/cureus.50225","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T15:47:41Z","timestamp":1702136861000},"source":"Crossref","is-referenced-by-count":2,"title":["A Case Report: Lithium-Induced Neurotoxicity, a Differential to Always Consider"],"prefix":"10.7759","author":[{"given":"Noah N","family":"Kronk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke K","family":"Kronk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed T","family":"Robbie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1949.02900280001001","article-title":"Lithium poisoning from the use of salt substitutes","volume":"139","author":"Corcoran AC","year":"1949","unstructured":"Corcoran AC, Taylor RD, Page IH. Lithium poisoning from the use of salt substitutes. J Am Med Assoc. 1949, 139:685-8. 10.1001\/jama.1949.02900280001001","journal-title":"J Am Med Assoc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2021.1989785","article-title":"2020 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 38th annual report","volume":"59","author":"Gummin DD","year":"2021","unstructured":"Gummin DD, Mowry JB, Beuhler MC, et al.. 2020 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 38th annual report. Clin Toxicol (Phila). 2021, 59:1282-501. 10.1080\/15563650.2021.1989785","journal-title":"Clin Toxicol (Phila)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/BF03259929","article-title":"Clinical features and management of lithium poisoning","volume":"3","author":"Amdisen A","year":"1988","unstructured":"Amdisen A. Clinical features and management of lithium poisoning. Med Toxicol Adverse Drug Exp. 1988, 3:18-32. 10.1007\/BF03259929","journal-title":"Med Toxicol Adverse Drug Exp"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2020.1726376","article-title":"Effect of age on the severity of chronic lithium poisoning","volume":"58","author":"Chan BS","year":"2020","unstructured":"Chan BS, Cheng S, Isoardi KZ, et al.. Effect of age on the severity of chronic lithium poisoning. Clin Toxicol (Phila). 2020, 58:1023-7. 10.1080\/15563650.2020.1726376","journal-title":"Clin Toxicol (Phila)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10021014","article-title":"Extracorporeal treatment for lithium poisoning: systematic review and recommendations from the Extrip Workgroup","volume":"10","author":"Decker BS","year":"2015","unstructured":"Decker BS, Goldfarb DS, Dargan PI, et al.. Extracorporeal treatment for lithium poisoning: systematic review and recommendations from the Extrip Workgroup. Clin J Am Soc Nephrol. 2015, 10:875-87. 10.2215\/CJN.10021014","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00096.x","article-title":"Lithium-induced nephropathy: rate of progression and prognostic factors","volume":"64","author":"Presne C","year":"2003","unstructured":"Presne C, Fakhouri F, No\u00ebl LH, et al.. Lithium-induced nephropathy: rate of progression and prognostic factors. Kidney Int. 2003, 64:585-92. 10.1046\/j.1523-1755.2003.00096.x","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"79","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2022, 79:1757-80. 10.1016\/j.jacc.2021.12.011","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31829e8776","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy CW","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al.. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2013, 128:e240-327. 10.1161\/CIR.0b013e31829e8776","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-022-01238-4","article-title":"Medicine-induced acute kidney injury findings from spontaneous reporting systems, sequence symmetry analysis and a case-control study with a focus on medicines used in primary care","volume":"45","author":"Roughead EE","year":"2022","unstructured":"Roughead EE, Kerr M, Moffat A, Kassie GM, Pratt N. Medicine-induced acute kidney injury findings from spontaneous reporting systems, sequence symmetry analysis and a case-control study with a focus on medicines used in primary care. Drug Saf. 2022, 45:1413-21. 10.1007\/s40264-022-01238-4","journal-title":"Drug Saf"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.09.011","article-title":"Mineralocorticoid receptor antagonists, blood pressure, and outcomes in heart failure with reduced ejection fraction","volume":"8","author":"Serenelli M","year":"2020","unstructured":"Serenelli M, Jackson A, Dewan P, et al.. Mineralocorticoid receptor antagonists, blood pressure, and outcomes in heart failure with reduced ejection fraction. JACC Heart Fail. 2020, 8:188-98. 10.1016\/j.jchf.2019.09.011","journal-title":"JACC Heart Fail"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-314158","article-title":"Change in renal function associated with drug treatment in heart failure: national guidance","volume":"105","author":"Clark AL","year":"2019","unstructured":"Clark AL, Kalra PR, Petrie MC, Mark PB, Tomlinson LA, Tomson CR. Change in renal function associated with drug treatment in heart failure: national guidance. Heart. 2019, 105:904-10. 10.1136\/heartjnl-2018-314158","journal-title":"Heart"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/205874-a-case-report-lithium-induced-neurotoxicity-a-differential-to-always-consider","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:33Z","timestamp":1707509373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/205874-a-case-report-lithium-induced-neurotoxicity-a-differential-to-always-consider"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,9]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.50225","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,9]]}}}